Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perlingeiro, R. C.R.
Right arrow Articles by Daley, G. Q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perlingeiro, R. C.R.
Right arrow Articles by Daley, G. Q.

Stem Cells 2003;21:272-280 www.StemCells.com
© 2003 AlphaMed Press

A Role for Thrombopoietin in Hemangioblast Development

Rita C.R. Perlingeiroa,b, Michael Kybaa, Susan Bodiea, George Q. Daleya,c

a Whitehead Institute, Cambridge, Massachusetts, USA;
b ViaCell, Inc., Cambridge, Massachusetts, USA;
c Division of Hematology/Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA

Key Words. Embryonic stem cells • Hemangioblast • Thrombopoietin • c-Mpl

George Q. Daley, M.D., Ph.D., Whitehead Institute, 9 Cambridge Center, Cambridge, Massachusetts 02142, USA. Phone: 617-258-7209; Fax: 617-258-5213; e-mail: daley{at}wi.mit.edu

Vascular endothelial growth factor (VEGF) and stem cell factor (SCF) act as growth factors for the hemangioblast, an embryonic progenitor of the hematopoietic and endothelial lineages. Because thrombopoietin (TPO) and its receptor, c-Mpl, regulate primitive hematopoietic populations, including bone marrow hematopoietic stem cells, we investigated whether TPO acts on the hemangioblasts that derive from differentiation of embryonic stem cells in vitro. Reverse transcriptase polymerase chain reaction analysis detected expression of c-Mpl beginning on day 3 of embryoid body differentiation when the hemangioblast first arises. In assays of the hemangioblast colony-forming cell (BL-CFC), TPO alone supported BL-CFC formation and nearly doubled the number of BL-CFC when added together with VEGF and SCF. When replated under the appropriate conditions, TPO-stimulated BL-CFC gave rise to secondary hematopoietic colonies, as well as endothelial cells, confirming their nature as hemangioblasts. Addition of a neutralizing anti-VEGF antibody did not block TPO enhancement of BL-CFC formation, suggesting that TPO acts independently of VEGF. These results establish that Mpl signaling plays a role in the earliest stages of hematopoietic development and that TPO represents a third growth factor influencing hemangioblast formation.




This article has been cited by other articles:


Home page
 DevelopmentHome page
L. Petit-Cocault, C. Volle-Challier, M. Fleury, B. Peault, and M. Souyri
Dual role of Mpl receptor during the establishment of definitive hematopoiesis
Development, August 15, 2007; 134(16): 3031 - 3040.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
R. C. R. Perlingeiro
Endoglin is required for hemangioblast and early hematopoietic development
Development, August 15, 2007; 134(16): 3041 - 3048.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
H. Yao, B. Liu, X. Wang, Y. Lan, N. Hou, X. Yang, and N. Mao
Identification of High Proliferative Potential Precursors with Hemangioblastic Activity in the Mouse Aorta-Gonad- Mesonephros Region
Stem Cells, June 1, 2007; 25(6): 1423 - 1430.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
G.-M. Zou, M.-H. Luo, A. Reed, M. R. Kelley, and M. C. Yoder
Ape1 regulates hematopoietic differentiation of embryonic stem cells through its redox functional domain
Blood, March 1, 2007; 109(5): 1917 - 1922.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. Tober, A. Koniski, K. E. McGrath, R. Vemishetti, R. Emerson, K. K. L. de Mesy-Bentley, R. Waugh, and J. Palis
The megakaryocyte lineage originates from hemangioblast precursors and is an integral component both of primitive and of definitive hematopoiesis
Blood, February 15, 2007; 109(4): 1433 - 1441.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
H. Priddle, D. R. E. Jones, P. W. Burridge, and R. Patient
Hematopoiesis from Human Embryonic Stem Cells: Overcoming the Immune Barrier in Stem Cell Therapies
Stem Cells, April 1, 2006; 24(4): 815 - 824.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. Wang, F. Yates, O. Naveiras, P. Ernst, and G. Q. Daley
Embryonic stem cell-derived hematopoietic stem cells
PNAS, December 27, 2005; 102(52): 19081 - 19086.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
H. Amano, N. R. Hackett, S. Rafii, and R. G. Crystal
Thrombopoietin Gene Transfer-Mediated Enhancement of Angiogenic Responses to Acute Ischemia
Circ. Res., August 19, 2005; 97(4): 337 - 345.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. P. Chute, G. G. Muramoto, J. Fung, and C. Oxford
Soluble factors elaborated by human brain endothelial cells induce the concomitant expansion of purified human BM CD34+CD38- cells and SCID-repopulating cells
Blood, January 15, 2005; 105(2): 576 - 583.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.stemcellsportal.com/
Copyright © 2003 by AlphaMed Press.